IMARC Group, a leading market research company, has released a report titled “Inhalation Anesthesia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. offers a comprehensive analysis of the industry, which comprises insights on the global inhalation anesthesia market share. The global market size reached US$ 1.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.9 Billion by 2028, exhibiting a growth rate (CAGR) of 3.4% during 2023-2028.

Inhalation anesthesia ensures patient comfort and safety during surgeries and various medical interventions. It is a medical practice that involves administering anesthesia through inhalation, allowing patients to enter a controlled state of unconsciousness. It is preferred for its rapid onset and reversibility, providing an effective means of sedation while minimizing the risks associated with deep anesthesia. It typically employs volatile liquid anesthetics, such as sevoflurane, isoflurane, and desflurane, which are vaporized and inhaled by the patient. Additionally, inhalation anesthetics are administered in precise concentrations through specialized equipment, ensuring a controlled and safe anesthetic experience. As a result, inhalation anesthesia is gaining immense popularity across the globe.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/inhalation-anesthesia-market/requestsample

Inhalation Anesthesia Market Trends and Drivers:

The global inhalation anesthesia market is driven by the increasing demand for surgical procedures, including routine and complex surgeries. In addition, the rising healthcare infrastructure, the growing aging population, and the need for surgeries and medical interventions are influencing the market growth. Also, inhalation anesthesia ensures patients undergo surgery comfortably and without pain, augmenting the market growth. Moreover, the shift toward more advanced and efficient inhalation anesthesia delivery systems providing greater control and precision in administering anesthesia is contributing to enhanced patient safety and improved outcomes, representing another major growth-inducing factor. Along with this, anesthesia machine manufacturers are continually innovating, integrating features including electronic gas mixing, automated monitoring, and advanced safety mechanisms, propelling the market growth. Besides this, the widespread adoption of inhalation anesthesia in ambulatory surgery centers and dental clinics into their practices for the convenience and flexibility of inhalation anesthesia allows them to perform numerous procedures and cater to a larger patient base, accelerating the product adoption rate. Along with this, the growing emphasis on patient safety and the reduction of greenhouse gas (GHG) emissions in healthcare settings led to the adoption of inhalation anesthesia, known for its minimal impact on the environment, propelling the market growth. Furthermore, healthcare facilities and professionals are opting for inhalation anesthesia over intravenous methods due to its lower carbon footprint, further creating a positive market outlook.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product:

• Desflurane
• Sevoflurane
• Isoflurane
• Others

Breakup by Application:

• Induction
• Maintenance

Breakup by End User:

• Hospitals
• Ambulatory Surgical Centers
• Others

Market Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Competitive Landscape with Key Player:

• Abbvie Inc.
• Baxter International Inc.
• Fresenius SE & Co. KGaA
• Halocarbon Products Corporation
• Hikma Pharmaceuticals PLC
• Lunan Pharmaceutical Group Co. Ltd
• Merck KGaA
• Piramal Enterprises Ltd.
• Troikaa Pharmaceuticals Ltd.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

Email: sales@imarcgroup.com

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal